Corcept Therapeutics Incorporated (BIT:1CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	6,705	4,558	2,890	1,885	1,805	2,628
Market Cap Growth	68.30%	57.70%	53.35%	4.41%	-31.31%	120.32%
Enterprise Value	6,267	4,234	2,573	1,513	1,613	2,249
PE Ratio	59.65	40.97	34.55	23.34	22.25	30.78
Forward PE	64.95	32.11	32.61	19.95	21.01	32.91
PS Ratio	11.00	7.85	6.96	5.45	5.73	8.63
PB Ratio	12.38	7.79	6.63	4.36	5.58	5.84
P/TBV Ratio	14.25	8.41	7.16	4.69	6.64	6.21
P/FCF Ratio	43.68	27.04	26.47	18.26	12.53	20.26
P/OCF Ratio	43.22	26.74	26.44	18.20	12.49	20.09
EV/Sales Ratio	10.17	7.29	6.20	4.38	5.12	7.39
EV/EBITDA Ratio	69.04	35.57	27.27	15.15	14.65	20.04
EV/EBIT Ratio	71.81	35.92	27.87	15.61	15.06	20.39
EV/FCF Ratio	40.83	25.11	23.56	14.66	11.19	17.34
Debt / Equity Ratio	0.01	0.01	0	0	0	0.00
Debt / EBITDA Ratio	0.06	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.87	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	0.64	0.68	0.39	0.31	0.27	0.29
Quick Ratio	2.81	3.11	4.05	6.58	5.28	9.83
Current Ratio	3.06	3.35	4.39	6.89	5.60	10.07
Return on Equity (ROE)	18.06%	30.65%	28.35%	29.84%	30.58%	35.15%
Return on Assets (ROA)	11.68%	21.09%	20.44%	25.21%	27.51%	31.12%
Return on Capital (ROIC)	26.31%	56.38%	89.12%	98.74%	108.19%	151.77%
Return on Capital Employed (ROCE)	15.03%	22.51%	20.87%	25.39%	27.65%	28.56%
Earnings Yield	1.68%	2.44%	2.89%	4.28%	4.49%	3.25%
FCF Yield	2.29%	3.70%	3.78%	5.48%	7.98%	4.94%
Buyback Yield / Dilution	0.34%	0.54%	4.43%	0.79%	14.43%	-0.40%
Total Shareholder Return	-	0.54%	4.43%	0.79%	14.43%	-0.40%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.